Similar Search Results

Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey

Baser, Onur; Baser, Erdem; Altinbas, Akif; Burkan, … - In: Health Economics Review 3 (2013) 5, pp. 1-7

Objective: This study aimed to apply the previously validated severity index for rheumatoid arthritis (SIFRA) to prevalent rheumatoid arthritis (RA) groups in Turkey and determine the effect of RA severity on health care costs and biologic use. Methods: This retrospective study used the Turkish...

Persistent link: https://www.econbiz.de/10010317179

Cost-Benefit Analysis of the FDA: The Case of the Prescription Drug User Fee Acts

Philipson, Tomas J.; Berndt, Ernst R.; Gottschalk, … - 2007

Persistent link: https://www.econbiz.de/10013342492

Productivity

Berndt, Ernst R. - In: NBER Reporter Online (2002) Spring 2002, pp. 1-6

Persistent link: https://www.econbiz.de/10010283820

Productivity

Berndt, Ernst R. - In: NBER Reporter Online (2006) Winter 2006/07, pp. 1-9

Persistent link: https://www.econbiz.de/10010287455

Interpreting changes in mental health expenditures: Minding our Ps and Qs

Berndt, Ernst R.; Busch, Susan H.; Frank, Richard G. - In: NBER Reporter Online (2000) Winter 2000/01, pp. 10-13

Persistent link: https://www.econbiz.de/10010289764